Skip to content
value.today

Aytu Bioscience vs Cell Source, Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Aytu Bioscience and Cell Source, Inc. are worth about the same: $21 M and $20 M (market caps of Oct 26, 2026 for Aytu Bioscience and Dec 25, 2022 for Cell Source, Inc.). Cell Source, Inc.'s value is the last on file, from Dec 25, 2022: no market-data feed is connected for its exchange yet.
  • Both made a net loss: $14 M for Aytu Bioscience and $5 M for Cell Source, Inc.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

01172343514682020202120222023202420252026Aytu Bioscience 94Cell Source, Inc. 69

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$0B$0B$0B$0B201820192020202120222023202420252026Aytu Bioscience $0B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureAytu Bioscience
AYTU · #24,234 in the world
Cell Source, Inc.
CLCS
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryBiotechnologyBiotechnology
Founded——
Size
Market cap$21 M$20 M*
Revenue$58 M—
Net income$-14 M$-5 M▲ best
Valuation
Price to sales0.4×—
Price to book0.6×—
Free cash flow yield15.7%—
Profitability
Gross margin64.0%—
Operating margin-14.4%—
Net margin-24.8%—
Return on equity-52.5%—
Growth
Revenue growth-13.3%—
Revenue growth, 3 years a year-18.8%—
Financial strength
Debt to equity0.3×—
Interest cover-4.4×—
Cash
Free cash flow margin5.7%—
Strength scores
Piotroski F-score4 of 9—
Altman Z-score zonedistress—
Data as ofMarket cap Oct 2026; ratios FY2026Market cap Dec 2022; ratios FY2024

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, Aytu Bioscience or Cell Source, Inc.?

Aytu Bioscience and Cell Source, Inc. are worth about the same: $21 M and $20 M (market caps of Oct 26, 2026 for Aytu Bioscience and Dec 25, 2022 for Cell Source, Inc.). Cell Source, Inc.'s value is the last on file, from Dec 25, 2022: no market-data feed is connected for its exchange yet.

Which makes more money, Aytu Bioscience or Cell Source, Inc.?

Both made a net loss: $14 M for Aytu Bioscience and $5 M for Cell Source, Inc.

Sources#

Every figure on this page comes from these, with the date shown next to it.